ANDEMBRY® received manufacturing and marketing approval in Japan on February 20, 2025, for the prevention of acute attacks in hereditary angioedema (HAE) ANDEMBRY® is the ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...

Preliminary Phase 2 data presented in November at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting showed that a combination of AU-007 and low-dose, subcutaneous aldesleukin is ...

AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing ...

Recently, the incidence of zoonoses has shown a global upward trend. There are more than 60 emerging infectious diseases and ...

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute ...

Likewise, inflammatory diseases may benefit from the targeted action ... multi-specific antibodies in neurodegenerative diseases and viral infections, where intricate disease mechanisms ...

Please discuss the class and complete drug profile of amyloid-targeting therapies for Alzheimer disease, including their mechanisms of action, efficacy, and safety profiles.

Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824, United States Department of Computational Mathematics, Science and Engineering, Michigan ...